American Century Companies’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-836,134
| Closed | -$24.8M | – | 2987 |
|
|
2023
Q4 | $24.8M | Buy |
836,134
+137,018
| +20% | +$2.73M | 0.02% | 792 |
|
|
2023
Q3 | $11.1M | Sell |
699,116
-1,207
| -0.2% | -$20.1K | 0.01% | 1029 |
|
|
2023
Q2 | $13.2M | Buy |
+700,323
| New | +$8.27M | 0.01% | 942 |
|
|
2022
Q1 | – | Sell |
-12,969
| Closed | -$96K | – | 2372 |
|
|
2021
Q4 | $96K | Hold |
12,969
| – | – | ﹤0.01% | 2261 |
|
|
2021
Q3 | $74K | Sell |
12,969
-2,013
| -13% | -$11.6K | ﹤0.01% | 2250 |
|
|
2021
Q2 | $99K | Sell |
14,982
-5,962
| -28% | -$41.6K | ﹤0.01% | 2237 |
|
|
2021
Q1 | $170K | Buy |
20,944
+10,301
| +97% | +$84.1K | ﹤0.01% | 2112 |
|
|
2020
Q4 | $69K | Buy |
+10,643
| New | +$62.1K | ﹤0.01% | 1938 |
|
|
2016
Q1 | – | Sell |
-113,550
| Closed | -$1.54M | – | 1383 |
|
|
2015
Q4 | $1.54M | Sell |
113,550
-377
| -0.3% | -$4.64K | ﹤0.01% | 1061 |
|
|
2015
Q3 | $1.09M | Buy |
113,927
+9,098
| +9% | +$133K | ﹤0.01% | 1103 |
|
|
2015
Q2 | $1.51M | Buy |
+104,829
| New | +$1.15M | ﹤0.01% | 1077 |
|
|
2014
Q4 | – | Sell |
-80,058
| Closed | -$848K | – | 1485 |
|
|
2014
Q3 | $848K | Buy |
80,058
+4,074
| +5% | +$46.1K | ﹤0.01% | 1212 |
|
|
2014
Q2 | $900K | Buy |
75,984
+23,304
| +44% | +$293K | ﹤0.01% | 1236 |
|
|
2014
Q1 | $787K | Sell |
52,680
-4,200
| -7% | -$66.2K | ﹤0.01% | 1269 |
|
|
2013
Q4 | $834K | Buy |
56,880
+170
| +0.3% | +$2.61K | ﹤0.01% | 1277 |
|
|
2013
Q3 | $965K | Buy |
56,710
+3,550
| +7% | +$62.4K | ﹤0.01% | 1237 |
|
|
2013
Q2 | $882K | Buy |
+53,160
| New | +$862K | ﹤0.01% | 1222 |
|
Other funds holding IMGN
American Century Companies's IMGN Position: Q1 2024 in Review
American Century Companies sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 836,134 shares — an estimated $24.8M sold.
American Century Companies first reported a position in IMGN in Q2 2013 and held it in 17 quarters. The position peaked at $24.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- American Century Companies reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- American Century Companies sold 836,134 Immunogen Inc shares in Q1 2024, an estimated $24.8M.
- American Century Companies first reported a position in Immunogen Inc in Q2 2013 and held it in 17 quarters.
- American Century Companies's Immunogen Inc position peaked at $24.8M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.